Cyclic GMP in urine to monitor the response to ovarian cancer to therapy

Guanosine 3':5'-phosphate (cycle GMP) in urine has been used to monitor the response of patients with ovarian cancer to treatment. Changes in the cyclic GMP level appear to correlate well with clinical status in that the disappearance of clinically detectable tumour is associated with a drop in the level whereas a tumour recurrence is associated with an elevation. Serially measured cyclic GMP is valuable for detecting a recurrence of tumour growth in patients in clinical remission and can predate any clinical signs by as much as 10 months. In patients who show no response to treatment, cyclic GMP levels in urine are elevated in the majority of specimens collected.     

适应形势更新观念注重实际

我们又进入了新的一年,像是翻阅着时代发展的精彩华章. 近年来,医学的进展、观念的更新,令人有夸父追日之慨;而妇产科学的长足进步,无论国际或国内的现状与前景,也让人振奋不已.